eli lilly: 136% qtrly increase in axiron sales

  1. 126 Posts.
    results released last night:

    third quarter Axiron sales revenue 5.2m vs second quarter 2.2m, these being the only full quarters since launch.

    as we know the prices are subsidised during the launch phase so at this point i am not focussed on the dollar value, rather the launch trajectory which looks very impressive.

    i haven't listened to the whole conf call, so if anyone picked up commentary on specific volumes/mkt penetration pls do share.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.8¢
Change
0.000(0.00%)
Mkt cap ! $7.366M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
5 883823 1.7¢
 

Sellers (Offers)

Price($) Vol. No.
1.8¢ 500697 1
View Market Depth
Last trade - 16.21pm 30/07/2025 (20 minute delay) ?
ACR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.